137 related articles for article (PubMed ID: 33868363)
1. Screening for Combination Cancer Therapies With Dynamic Fuzzy Modeling and Multi-Objective Optimization.
Spolaor S; Scheve M; Firat M; Cazzaniga P; Besozzi D; Nobile MS
Front Genet; 2021; 12():617935. PubMed ID: 33868363
[TBL] [Abstract][Full Text] [Related]
2. Identification of Cancer-associated metabolic vulnerabilities by modeling multi-objective optimality in metabolism.
Dai Z; Yang S; Xu L; Hu H; Liao K; Wang J; Wang Q; Gao S; Li B; Lai L
Cell Commun Signal; 2019 Oct; 17(1):124. PubMed ID: 31601242
[TBL] [Abstract][Full Text] [Related]
3. Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells.
Nobile MS; Votta G; Palorini R; Spolaor S; De Vitto H; Cazzaniga P; Ricciardiello F; Mauri G; Alberghina L; Chiaradonna F; Besozzi D
Bioinformatics; 2020 Apr; 36(7):2181-2188. PubMed ID: 31750879
[TBL] [Abstract][Full Text] [Related]
4. Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity.
Pavel AB; Sonkin D; Reddy A
BMC Syst Biol; 2016 Feb; 10():16. PubMed ID: 26864072
[TBL] [Abstract][Full Text] [Related]
5. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
6. Design of multi-drug combinations for poly-pharmacological effects using composition-activity relationship modeling and multi-objective optimization approach: Application in traditional Chinese medicine.
Fan B; Li Y; Bi Y; Tong L; Li D; Wang Y
Chem Biol Drug Des; 2019 Jun; 93(6):1073-1082. PubMed ID: 30230238
[TBL] [Abstract][Full Text] [Related]
7. Taxane-based Combination Therapies for Metastatic Prostate Cancer.
Corn PG; Agarwal N; Araujo JC; Sonpavde G
Eur Urol Focus; 2019 May; 5(3):369-380. PubMed ID: 29275145
[TBL] [Abstract][Full Text] [Related]
8. Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine Deficiency.
Hsu KC; Wang FS
PLoS One; 2016; 11(10):e0164589. PubMed ID: 27736960
[TBL] [Abstract][Full Text] [Related]
9. Liquid temperature prediction in bubbly flow using ant colony optimization algorithm in the fuzzy inference system as a trainer.
Babanezhad M; Behroyan I; Nakhjiri AT; Marjani A; Heydarinasab A; Shirazian S
Sci Rep; 2020 Dec; 10(1):21884. PubMed ID: 33318542
[TBL] [Abstract][Full Text] [Related]
10. Fuzzy optimization for identifying anti-cancer targets with few side effects in constraint-based models of head and neck cancer.
Wang FS; Chen PR; Chen TY; Zhang HX
R Soc Open Sci; 2022 Oct; 9(10):220633. PubMed ID: 36303939
[TBL] [Abstract][Full Text] [Related]
11. Probabilistic Fatigue/Creep Optimization of Turbine Bladed Disk with Fuzzy Multi-Extremum Response Surface Method.
Zhang CY; Yuan ZS; Wang Z; Fei CW; Lu C
Materials (Basel); 2019 Oct; 12(20):. PubMed ID: 31618933
[TBL] [Abstract][Full Text] [Related]
12. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
Yeang CH; Beckman RA
Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
[TBL] [Abstract][Full Text] [Related]
13. Systems Perturbation Analysis of a Large-Scale Signal Transduction Model Reveals Potentially Influential Candidates for Cancer Therapeutics.
Puniya BL; Allen L; Hochfelder C; Majumder M; Helikar T
Front Bioeng Biotechnol; 2016; 4():10. PubMed ID: 26904540
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Oncogenic Kinases: An In Vitro Validated Computational Approach Identified Potential Multi-Target Anticancer Compounds.
Ikram N; Mirza MU; Vanmeert M; Froeyen M; Salo-Ahen OMH; Tahir M; Qazi A; Ahmad S
Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30925835
[TBL] [Abstract][Full Text] [Related]
15. Drug Sensitivity Screening and Targeted Pathway Analysis Reveal a Multi-Driver Proliferative Mechanism and Suggest a Strategy of Combination Targeted Therapy for Colorectal Cancer Cells.
Shen J; Li L; Yang T; Cheng N; Sun G
Molecules; 2019 Feb; 24(3):. PubMed ID: 30754629
[TBL] [Abstract][Full Text] [Related]
16. A recurrent fuzzy-neural model for dynamic system identification.
Mastorocostas PA; Theocharis JB
IEEE Trans Syst Man Cybern B Cybern; 2002; 32(2):176-90. PubMed ID: 18238117
[TBL] [Abstract][Full Text] [Related]
17. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
18. Multi-objective evolutionary algorithms for fuzzy classification in survival prediction.
Jiménez F; Sánchez G; Juárez JM
Artif Intell Med; 2014 Mar; 60(3):197-219. PubMed ID: 24525210
[TBL] [Abstract][Full Text] [Related]
19. Fuzzy Multi-SVR Learning Model for Reliability-Based Design Optimization of Turbine Blades.
Zhang CY; Wang Z; Fei CW; Yuan ZS; Wei JS; Tang WZ
Materials (Basel); 2019 Jul; 12(15):. PubMed ID: 31344790
[TBL] [Abstract][Full Text] [Related]
20. Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.
Barrette AM; Bouhaddou M; Birtwistle MR
ACS Chem Neurosci; 2018 Jan; 9(1):118-129. PubMed ID: 28950062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
